ALLIANCE A091605

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Skin

Status:

Open

A Randomized Phase II Study of Anti-PD1 Antibody [MK-3475 (Pembrolizumab)] Alone Versus Anti-PD1 Antibody Plus Stereotactic Body Radiation Therapy in Advanced Merkel Cell Carcinoma

NCT#03304639